Published in Int J Cancer on May 15, 2008
Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer. BMC Cancer (2010) 0.97
A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis. Cancer Cell (2015) 0.97
An essential role for Ran GTPase in epithelial ovarian cancer cell survival. Mol Cancer (2010) 0.93
Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways. Clin Cancer Res (2011) 0.92
The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells. BMC Cancer (2014) 0.85
Thioredoxin-like protein 2 is overexpressed in colon cancer and promotes cancer cell metastasis by interaction with ran. Antioxid Redox Signal (2013) 0.84
High Ran level is correlated with poor prognosis in patients with colorectal cancer. Int J Clin Oncol (2012) 0.84
Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer. PLoS One (2015) 0.82
Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma. Cancer Immunol Immunother (2011) 0.81
RanGTPase: A Key Regulator of Nucleocytoplasmic Trafficking. Mol Cell Pharmacol (2009) 0.79
RAN GTPase and Osteopontin in Pancreatic Cancer. Pancreat Disord Ther (2013) 0.79
Characterization of a novel activated Ran GTPase mutant and its ability to induce cellular transformation. J Biol Chem (2012) 0.78
Inter-cellular transport of ran GTPase. PLoS One (2015) 0.77
Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS. Oncotarget (2016) 0.77
Genetic variants in RAN, DICER and HIWI of microRNA biogenesis genes and risk of cervical carcinoma in a Chinese population. Chin J Cancer Res (2013) 0.77
Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the expression of AR and CXCR4. Cancer Biol Ther (2014) 0.76
Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res (2003) 2.52
Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg (2008) 2.43
NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. Cancer Res (2008) 2.01
CRMP-2 is involved in kinesin-1-dependent transport of the Sra-1/WAVE1 complex and axon formation. Mol Cell Biol (2005) 1.64
Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res (2004) 1.58
Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer. Int J Urol (2015) 1.43
The relationship between FDG uptake in PET scans and biological behavior in breast cancer. Breast Cancer (2007) 1.23
Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J Clin Endocrinol Metab (2012) 1.17
Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis. Cancer Sci (2011) 1.11
Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int (2002) 1.10
Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma. Pathol Int (2005) 1.09
Recent advances in the treatment of metastatic renal cell carcinoma. Int J Urol (2013) 1.08
Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer. Breast Cancer (2012) 1.06
Gastric schwannomas show an obviously increased fluorodeoxyglucose uptake in positron emission tomography: report of two cases. Surg Today (2011) 1.05
Two cases of breast cancer with cartilaginous and osseous metaplasia. Breast Cancer (2005) 1.04
PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors. Pathol Int (2005) 1.03
Identification and characterization of taxilin isoforms. Biochem Biophys Res Commun (2004) 1.01
Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in stage I adenocarcinomas of the lung. Pathol Int (2002) 1.00
Immunohistochemical evaluation for hormone receptors in breast cancer: a practically useful evaluation system and handling protocol. Breast Cancer (2006) 0.99
Cellular composition of subacute thyroiditis. an immunohistochemical study of six cases. Pathol Res Pract (2002) 0.98
Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer. BMC Cancer (2013) 0.97
Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer. BMC Cancer (2010) 0.97
Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma. Histopathology (2014) 0.94
Interaction of the taxilin family with the nascent polypeptide-associated complex that is involved in the transcriptional and translational processes. Genes Cells (2005) 0.94
Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis. Pathol Int (2004) 0.93
A new prognostic classification for overall survival in Asian patients with previously untreated metastatic renal cell carcinoma. Cancer Sci (2012) 0.93
Keratin 17 expression correlates with tumor progression and poor prognosis in gastric adenocarcinoma. Ann Surg Oncol (2012) 0.92
Possible role of the RhoC/ROCK pathway in progression of clear cell renal cell carcinoma. Biomed Res (2008) 0.91
Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers. Pathol Int (2004) 0.90
A case of mesenteric cystic lymphangioma in an adult which caused duodenal stenosis after resection. Int J Surg Case Rep (2012) 0.90
Renal metanephric adenoma mimicking papillary renal cell carcinoma on computed tomography: a case report. Urol Int (2012) 0.90
Lymph node lesion in adult-onset Still's disease resembling peripheral T-cell lymphoma: a report of three cases. Int J Surg Pathol (2002) 0.89
Urodynamic effects of silodosin, a new alpha 1A-adrenoceptor selective antagonist, for the treatment of benign prostatic hyperplasia. Neurourol Urodyn (2010) 0.88
The role of M2 muscarinic receptor subtypes mediating contraction of the circular and longitudinal smooth muscle of the pig proximal urethra. J Urol (2002) 0.88
Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma. Cancer Sci (2014) 0.88
Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays. Am J Clin Pathol (2007) 0.88
Management of benign prostatic hyperplasia with silodosin. Open Access J Urol (2009) 0.87
STAT3 polymorphism can predict the response to interferon-α therapy in patients with metastatic renal cell carcinoma. Eur Urol (2012) 0.87
Taxilin; a novel syntaxin-binding protein that is involved in Ca2+-dependent exocytosis in neuroendocrine cells. Genes Cells (2003) 0.87
Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma. Virchows Arch (2009) 0.87
Diagnostic usefulness of ¹⁸F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma. Eur J Nucl Med Mol Imaging (2013) 0.86
Up-regulation of a BCL9-related beta-catenin-binding protein, B9L, in different stages of sporadic colorectal adenoma. Cancer Sci (2007) 0.86
Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma. Hepatol Res (2014) 0.86
Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma. BMC Cancer (2013) 0.86
Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia. Int J Urol (2004) 0.86
Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int J Urol (2004) 0.86
Neoadjuvant weekly paclitaxel with and without trastuzumab in locally advanced or metastatic breast cancer. Anticancer Res (2009) 0.86
Comparison of L-type amino acid transporter 1 expression and L-[3-18F]-α-methyl tyrosine uptake in outcome of non-small cell lung cancer. Nucl Med Biol (2010) 0.86
Centroblastic and centroblastic/centrocytic lymphoma associated with a prominent epithelioid granulomatous response: a clinicopathologic study of 50 cases. Mod Pathol (2002) 0.85
Neuromodulation for the treatment of urinary incontinence. Int J Urol (2008) 0.85
Triple-negative breast cancer: histological subtypes and immunohistochemical and clinicopathological features. Cancer Sci (2011) 0.85
The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells. BMC Cancer (2014) 0.85
Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis. BMC Cancer (2007) 0.85
Single minimum incision endoscopic radical nephrectomy for renal tumors with preoperative virtual navigation using 3D-CT volume-rendering. BMC Urol (2010) 0.85
Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma. Cancer Sci (2014) 0.84
[A case report: testicular pure seminoma metastasized to costal bone after 2 years post-operatively]. Hinyokika Kiyo (2004) 0.84
Luteinizing hormone (LH)-releasing hormone agonist reduces serum adrenal androgen levels in prostate cancer patients: implications for the effect of LH on the adrenal glands. J Androl (2012) 0.84
Developmental and spatial expression pattern of alpha-taxilin in the rat central nervous system. J Comp Neurol (2008) 0.83
Immunohistochemical expression of the beta-catenin-interacting protein B9L is associated with histological high nuclear grade and immunohistochemical ErbB2/HER-2 expression in breast cancers. Cancer Sci (2007) 0.83
Multimerization of anti-(epidermal growth factor receptor) IgG fragments induces an antitumor effect: the case for humanized 528 scFv multimers. FEBS J (2013) 0.83
Dilated cardiomyopathy as a presenting feature of Cushing's syndrome. Intern Med (2013) 0.83
Expression of α-taxilin in the murine gastrointestinal tract: potential implication in cell proliferation. Histochem Cell Biol (2013) 0.82
[A case of eosinophilic cystitis that was treated with oral suplatast tosilate (IPD-1151T)]. Hinyokika Kiyo (2009) 0.82
Pathological complete response and prognosis in patients receiving neoadjuvant paclitaxel and trastuzumab with and without anthracyclines for stage II and III, HER2-positive operable breast cancer: a single-institute experience. Anticancer Res (2011) 0.82
Bizarre parosteal osteochondromatous proliferation of the maxilla: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 0.82
Expression of RhoA mRNA and activated RhoA in urothelium and smooth muscle, and effects of a Rho-kinase inhibitor on contraction of the porcine urinary bladder. Neurourol Urodyn (2009) 0.82
Local control by breast-conserving surgery with nipple resection. Anticancer Res (2005) 0.82
Progressive transformation of germinal centers: a clinicopathological study of 42 Japanese patients. Int J Surg Pathol (2003) 0.82
Role of beta-adrenoceptor subtypes in mediating relaxation of the pig bladder trigonal muscle in vitro. Neurourol Urodyn (2003) 0.82
Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer. Breast Cancer (2011) 0.82
Increased alpha-taxilin protein expression is associated with the metastatic and invasive potential of renal cell cancer. Biomed Res (2011) 0.82
Expression of α-taxilin in hepatocellular carcinoma correlates with growth activity and malignant potential of the tumor. Int J Oncol (2010) 0.81
Randomized prospective comparison of fosfomycin and cefotiam for prevention of postoperative infection following urological surgery. J Infect Chemother (2007) 0.81
Protein profiling of blood samples from patients with hereditary leiomyomatosis and renal cell cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Int J Mol Sci (2012) 0.81
Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma. Cancer Immunol Immunother (2011) 0.81
Immunohistochemical demonstration of 14-3-3 sigma protein in normal human tissues and lung cancers, and the preponderance of its strong expression in epithelial cells of squamous cell lineage. Pathol Int (2003) 0.81
Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication]. Endocr J (2014) 0.81
Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer. Exp Ther Med (2011) 0.81
Prognostic significance of global grading system of Gleason score in patients with prostate cancer with bone metastasis. BJU Int (2009) 0.81